NCT03523390 2024-02-23Phase I/Ib Multiple Ascending Dose Study in ChinaMerck KGaA, Darmstadt, GermanyPhase 1 Completed24 enrolled 24 charts
NCT03399552 2023-10-23Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant MesotheliomaMemorial Sloan Kettering Cancer CenterPhase 1/2 Completed15 enrolled 8 charts